German Cancer Research Center
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.dkfz.de
Clinical Trials
48
Active:4
Completed:25
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:9
Phase 2:6
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (33 trials with phase data)• Click on a phase to view related trials
Not Applicable
17 (51.5%)Phase 1
9 (27.3%)Phase 2
6 (18.2%)Early Phase 1
1 (3.0%)Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers
Not yet recruiting
- Conditions
- Rare Cancer
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 946
- Registration Number
- NCT06855134
Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
Recruiting
- Conditions
- Melanoma (Skin Cancer)Artificial Intelligence (AI)Pediatric Cancer
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 3000
- Registration Number
- NCT06621810
- Locations
- 🇩🇪
University of Tübingen, Tübingen, Germany
🇮🇹University of Florence, Florence, Italy
🇪🇸Hospital Clínic de Barcelona, Barcelona, Spain
Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study
Not Applicable
Completed
- Conditions
- Cancer Prevention
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 1422
- Registration Number
- NCT06614673
- Locations
- 🇩🇪
German Cancer Research Center, Heidelberg, Germany
Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO)
Not Applicable
Not yet recruiting
- Conditions
- Cancer Prevention
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 40
- Registration Number
- NCT06026384
- Locations
- 🇩🇪
German Cancer Research Center, Heidelberg, Germany
FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Phase 1
Recruiting
- Conditions
- Colorectal CancerBreast CarcinomaSarcomaPenile Carcinoma
- Interventions
- Drug: Administration of CC-3
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 89
- Registration Number
- NCT05999396
- Locations
- 🇩🇪
University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
No news found